Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jan 2019 for Seelos Therapeutics, INC., €6,519.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Neil Morton: trading record in brief
This profile gathers the share dealings of Neil Morton in Seelos Therapeutics, Inc. We count 10 filings; the first trade dates from 25 April 2016 and the latest from 23 January 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 24 January 2019, the filings show a share grant worth €6,519 in Seelos Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Neil Morton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
32,705 shares@ US$0.2265Common StockSEC:0000899243-19-001840:0
12,968 shares@ US$0.306100.0% of flowCommon StockSEC:0000899243-18-029913:0
2,194 shares@ US$1.84Common StockSEC:0001017491-18-000005:0
14,093 shares@ US$1.5683.0% of flowCommon StockSEC:0001017491-17-000102:0
75,000 sharesCommon StockSEC:0001017491-17-000088:0
831 shares@ US$2.78Common StockSEC:0001017491-17-000036:0
75,000 sharesCommon StockSEC:0001017491-17-000015:0
0Common StockSEC:0001017491-16-000176:0
100,000 sharesCommon StockSEC:0001017491-16-000179:0
100,000 sharesCommon StockSEC:0001017491-16-000155:0
10 of 10 declarations
